Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Diagnosis and Management of Complicated Intra-abdominal Infection in Adults and Children: Guidelines by the Surgical Infection Society and the Infectious Diseases Society of America
2009 Standout
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
Monitoring Sedation Status Over Time in ICU Patients
2003 Standout
Alfentanil pharmacokinetics in patients undergoing abdominal aortic surgery
1991
Cyclodextrins as pharmaceutical solubilizers
2007 Standout
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole
1994
Recommendations for managing Aspergillus osteomyelitis and joint infections based on a review of the literature
2005
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes
2004
Itraconazole
1989
Itraconazole trough concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl‐β‐cyclodextrin oral solution or coated‐pellet capsules
1999
Practice Guidelines for the Treatment of Candidiasis
2000
Methotrexate modulates the kinetics of adenosine in humans in vivo
2005
Hypervalent iodine reagents as a new entrance to organocatalysts
2009 Standout
Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
2005 Standout
Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children
2006
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
Itraconazole to Prevent Fungal Infections in Chronic Granulomatous Disease
2003
A Factorial Trial of Six Interventions for the Prevention of Postoperative Nausea and Vomiting
2004 Standout
Intravenous Itraconazole Followed by Oral Itraconazole in the Treatment of Invasive Pulmonary Aspergillosis in Patients with Hematologic Malignancies, Chronic Granulomatous Disease, or AIDS
2001
Systemically Administered Antifungal Agents
1992
Antifungal Agents. Part II. The Azoles
1999
Cisapride
1994
Intravenous Itraconazole followed by Oral Itraconazole for the Treatment of Amphotericin-B-Refractory Invasive Pulmonary Aspergillosis
2003
Top-down production of drug nanocrystals: Nanosuspension stabilization, miniaturization and transformation into solid products
2008
Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia
1995
Suspensions for intravenous (IV) injection: A review of development, preclinical and clinical aspects
2008
Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis—State of the Art: Cystic Fibrosis Foundation Consensus Conference
2003
Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
2013
Review of Newer Antifungal and Immunomodulatory Strategies for Invasive Aspergillosis
2003
Voriconazole Therapeutic Drug Monitoring in Patients with Invasive Mycoses Improves Efficacy and Safety Outcomes
2007 Standout
Itraconazole: an effective oral antifungal for onychomycosis
2001
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
Fluconazole
1990
Pharmacokinetics and Pharmacodynamics of Sedatives and Analgesics in the Treatment of Agitated Critically Ill Patients
1997
Discovery and SAR of N-(1-((substituted piperidin-4-yl)methyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide derivatives: 5-Hydroxytryptamine receptor 4 agonist as a potent prokinetic agent
2015
The influence of cisapride and clarithromycin on QT intervals in healthy volunteers
1998
Galantamine for Alzheimer's disease
2010
Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole
1994
Characterization of the interaction of 2‐hydroxypropyl‐β‐cyclodextrin with itraconazole at pH 2, 4, and 7
2002
Successful Treatment of Multiple Cerebral Histoplasmomas with Itraconazole
1999
Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation
1998
Effect of food on the pharmacokinetics of multiple‐dose oral voriconazole
2003
Itraconazole: pharmacology, clinical experience and future development
1996
Clinical Pharmacology of Systemic Antifungal Agents: A Comprehensive Review of Agents in Clinical Use, Current Investigational Compounds, and Putative Targets for Antifungal Drug Development
1998
Effect of a Cola Beverage on the Bioavailability of Itraconazole in the Presence of H2 Blockers
1997
Sedation, Analgesia, and Paralysis in the Intensive Care Unit
1993
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
A Double-Blind, Randomized, Placebo-Controlled Trial of Itraconazole Capsules as Antifungal Prophylaxis for Neutropenic Patients
2000
Influence of Age and Gender on the Pharmacokinetics and Pharmacodynamics of Remifentanil
1997 Standout
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
1997
Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole
1996
Adjunctive Therapy of Allergic Bronchopulmonary Aspergillosis with Itraconazole
1991
A review of central 5-HT receptors and their function
1999 Standout
Oral Azole Drugs as Systemic Antifungal Therapy
1994
Cisapride
1988
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
2008 Standout
Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics
2001
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Antifungal agents: An overview. Part II
1994
Itraconazole
1996
Preparation and in-vitro release rate of fentanyl–cyclodextrin complexes for prolonged action in epidural analgesia
2003
Prevention and Treatment of Postoperative Nausea and Vomiting
2000
Stereochemical comparison of nebivolol with other β‐blockers
2007
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients
2006
Successful Treatment of Ventriculitis Due to Carbapenem‐ResistantAcinetobacter baumanniiwith Intraventricular Colistin Sulfomethate Sodium
1999
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
Candida Infections of Medical Devices
2004 Standout
Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics.
2007
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Intravenous Itraconazole
2001
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Zygomycetes in Human Disease
2000 Standout
Characterization of an azole-resistant Candida glabrata isolate
1992
Triazole antifungal agents drug–drug interactions involving hepatic cytochrome P450
2011
Aromatase inhibitors as potential cancer chemopreventives.
1998
Human Pharmacogenomic Variations and Their Implications for Antifungal Efficacy
2006
Nanoencapsulation, Nano-guard for Pesticides: A New Window for Safe Application
2016 Standout
Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
1999 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Current and Emerging Azole Antifungal Agents
1999 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
AspergillusInfections in Transplant Recipients
2005
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Invasive Candidiasis
2015 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Synthesis and Pharmacology of Galantamine
2005
Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations
1993
2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer
2002 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Antifungal Therapeutic Drug Monitoring: Established and Emerging Indications
2008
Pharmacology of Systemic Antifungal Agents
2006
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Optimisation of Itraconazole Therapy Using Target Drug Concentrations
1998
Successful Treatment of Cerebral Aspergillosis with a High Oral Dose of Itraconazole after Excisional Surgery.
1999
Nebivolol
2006
Comparison of Itraconazole and Fluconazole Treatments in a Murine Model of Coccidioidal Meningitis
2006
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
In Vitro Susceptibilities of Clinical Isolates of Candida Species, Cryptococcus neoformans , and Aspergillus Species to Itraconazole: Global Survey of 9,359 Isolates Tested by Clinical and Laboratory Standards Institute Broth Microdilution Methods
2005
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Itraconazole Prevents Invasive Fungal Infections in Neutropenic Patients Treated for Hematologic Malignancies: Evidence From a Meta-Analysis of 3,597 Patients
2003
Pharmacology of Itraconazole
2001
Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Guidelines for Treatment of Candidiasis
2004 Standout
Part 14: Pediatric Advanced Life Support
2010 Standout
Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America
2007 Standout
Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis
1997
Works of A. Van Peer being referenced
PHARMACOKINETICS OF ALFENTANIL DURING AND AFTER A FIXED RATE INFUSION
1989
The effects of food and dose on the oral systemic availability of itraconazole in healthy subjects
1989
New non-steroidal aromatase inhibitors: Focus on R76713
1990
PHARMACOKINETICS OF DROPERIDOL IN SURGICAL PATIENTS UNDER DIFFERENT CONDITIONS OF ANAESTHESIA
1988
Pharmacokinetics of sufentanil in general surgical patients under different conditions of anaesthesia
1993
Comparative bioavailability of a cisapride suppository and tablet formulation in healthy volunteers
1990
The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
2002
Alfentanil kinetics in renal insufficiency
1986
Pharmacokinetics of Itraconazole and Hydroxyitraconazole in Healthy Subjects after Single and Multiple Doses of a Novel Formulation
2006
Pharmacokinetics of oral antifungals and their clinical implications.
1990
Cisapride-Cimetidine Interaction
1989
Itraconazole pharmacokinetics in patients with renal dysfunction
1988
Excretion and biotransformation of cisapride in dogs and humans after oral administration.
1988
Clinical Pharmacokinetics of Nebivolol
1991
Alfentanil pharmacokinetics in preterm infants.
1990
Physiological Red Blood Cell Kinetic Model to Explain the Apparent Discrepancy Between Adenosine Breakdown Inhibition and Nucleoside Transporter Occupancy of Draflazine
1998
Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units
1997
Bioavailability of three oral dosage forms of cisapride, a gastrointestinal stimulant agent.
1987
The Clinical Pharmacokinetics of Itraconazole: An Overview
1989